Pulmo AB 200mg Tablet SR
Marketer
Zenni Pharmaceutical Private Limited
Salt Composition
Acebrophylline (200mg)
Overview Pulmo AB 200mg Tablet SR
BronchEase 200mg Extended-Release Tablets are indicated for managing and preventing asthma, bronchitis, and chronic obstructive pulmonary disease (COPD) symptoms. This medication relaxes airway muscles, improving airflow and easing breathing. BronchEase 200mg ER Tablets should be taken with an evening meal, consistently at the same time daily for optimal results. Dosage and frequency depend on the condition being treated; your physician will determine the appropriate regimen to alleviate your symptoms. Continue taking this medication as prescribed. Missed doses should be taken as soon as remembered, or if significantly delayed, omitted and the regular schedule resumed. Note that this medication does not provide immediate relief or prevent acute breathing difficulties; therefore, always carry a rescue inhaler. Common side effects may include stomach upset, bloating, nausea, vomiting, diarrhea, constipation, and heartburn. Report any concerning or persistent side effects to your doctor; management strategies may be available. Avoid alcohol and tobacco use during treatment. Prior to commencing treatment, inform your doctor of any kidney, liver, or heart conditions, and of all other medications you are currently using, as interactions may affect efficacy or alter the medication's action. Disclose pregnancy or breastfeeding status before starting this medication.
Primary Ingredients of Pulmo AB 200mg Tablet SR
No text provided to rephrase.
Uses of Pulmo AB 200mg Tablet SR
Managing Asthma, Bronchitis, and Chronic Obstructive Pulmonary Disease (COPD)
Major Benefits of Pulmo AB 200mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Pulmo AB 200mg Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Consume with food.
Common Side effects of Pulmo AB 200mg Tablet SR:
- Vomiting
- Abdominal pain
- Drowsiness
- Heartburn
- Increased white blood cell count
- Loss of appetite
- Rash
- Itching
- Constipation
- Diarrhea
- Abdominal discomfort
- Abdominal distension
- Esophageal bleeding
- Red spots or bumps
- Breathing problems
- High white blood cell count
- Nasal inflammation
How to use Pulmo AB 200mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Pulmo AB 200mg Sustained-Release Tablets should be administered with a meal.
How Pulmo AB 200mg Tablet SR works:
Pulmo AB 200mg Extended-Release Tablets combine mucolytic and bronchodilatory actions. The medication eases breathing by relaxing airway muscles and liquefying thick mucus.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Pulmo AB 200mg sustained-release tablets and alcohol may result in significant somnolence.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Pulmo AB 200mg sustained-release tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Pulmo AB 200mg sustained-release tablets with breastfeeding are lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Pulmo AB 200mg sustained-release tablets.
KidneyCAUTION
Patients with kidney impairment should use Pulmo AB 200mg SR tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Pulmo AB 200mg sustained-release tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Pulmo AB 200mg Tablet SR :
Should you forget a dose of Pulmo AB 200mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Pulmo AB 200mg Tablet SR
| Label | Value |
|---|---|
| Chemical Type | Methylxanthines |
| Developing Habits | No. |
| Treatment Category | Breathing |
| Action Class | Theophylline-based medications |


